BRIEF: MedBot reports strong year-to-date sales as commercialization accelerates
Shanghai MicroPort MedBot (Group) Co. Ltd. (2252.HK) said on Wednesday that cumulative orders for its core products, including laparoscopic, orthopedic, and vascular intervention surgical robots, surpassed 170 units as of…
Recent Articles
RELATED ARTICLES
-
BRIEF: MicroPort ‘s revenue soars in first half of 2025
2252.HK
-
Feihe’s sliding profits point to China dairy market past its sell-by date
6186.HK
-
BRIEF: EHang reports wider loss, slashes 2025 revenue guidance
EH.US
-
BRIEF: TCL reports strong first-quarter growth on popularity of large TVs
1070.HK
-
BRIEF: Meitu reports strong profit growth in first half of 2025
1357.HK
- China’s robotaxi commercialization faces hidden barriers
-
Tuya accelerates AI strategy with 93% of shipped products featuring full AI integration
TUYA.US 2391.HK
